Harnessing the upper respiratory microbiota for the development of novel biotherapeutics for childhood respiratory infections

Matthew Kelly, M.D., M.P.H., Duke University, Department of Pediatrics (Infectious Diseases), Global Health, and Molecular Genetics & Microbiology Associate Director, Duke Microbiome Center